Alector to Present at the Stifel 2021 Virtual Healthcare Conference
Alector, a clinical-stage biotechnology company based in South San Francisco, is announcing its participation in the Stifel 2021 Virtual Healthcare Conference. CEO Arnon Rosenthal will engage in a fireside chat on November 15, 2021, at 2:00 p.m. ET. A live webcast of the session will be accessible on Alector's Investors section. Alector specializes in immuno-neurology, focusing on innovative treatments for neurodegenerative diseases, with ongoing developments targeting conditions such as frontotemporal dementia and Alzheimer's disease. A replay of the event will be available for 90 days.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that Arnon Rosenthal, Ph.D., Chief Executive Officer of Alector, will participate in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on Monday, November 15, 2021, at 2:00 p.m. ET.
A live webcast of the fireside chat will be available on the “Events & Presentations” page within the Investors section of the Alector website at http://investors.alector.com. A replay will be available on the Alector website for 90 days following the event.
About Alector
Alector is a clinical-stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. Alector has discovered and is developing a broad portfolio of innate immune system programs, designed to functionally repair genetic mutations that cause dysfunction of the brain’s immune system and enable the rejuvenated immune cells to counteract emerging brain pathologies. Alector’s immuno-neurology product candidates are supported by biomarkers and target genetically defined patient populations in frontotemporal dementia and Alzheimer’s disease. This scientific approach is also the basis for the company’s immuno-oncology programs. Alector is headquartered in South San Francisco, California. For additional information, please visit www.alector.com.
Contacts
1AB
Dan Budwick
973-271-6085
dan@1abmedia.com
or
Investors:
Alector, Inc.
ir@alector.com
FAQ
What is Alector's participation in the Stifel 2021 Virtual Healthcare Conference?
How can I watch Alector's fireside chat?
When will Alector's fireside chat replay be available?
What is Alector's focus in biotechnology?
Where is Alector based?
